カテゴリー： QYResearch, 世界

世界の腎線維症治療市場 2019年

【英語タイトル】Global Kidney (Renal) Fibrosis Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X10187）・商品コード：DATA909X10187
・発行会社（調査会社）：QYResearch
・発行日：2019年11月20日（※2024年版があります。お問い合わせください）
・ページ数：106
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、腎線維症治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、アンジオテンシン変換酵素（ACE）阻害剤、ピルフェニドン、レニン阻害剤、アンジオテンシンII受容体遮断薬（ARB）、バソペプチダーゼ阻害剤に、用途別には、研究センター、病院、クリニックにセグメント区分し、腎線維症治療の世界市場を分析しました。


・エグゼクティブ・サマリー
・腎線維症治療の世界市場概要
・腎線維症治療の製造コスト構成分析
・腎線維症治療の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・腎線維症治療の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・腎線維症治療のセグメント分析（種類別）
（アンジオテンシン変換酵素（ACE）阻害剤、ピルフェニドン、レニン阻害剤、アンジオテンシンII受容体遮断薬（ARB）、バソペプチダーゼ阻害剤）
・腎線維症治療のセグメント分析（用途別）
（研究センター、病院、クリニック）
・腎線維症治療の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Merck、Pfizer、Roche、InterMune、Galectin Therapeutics、La Jolla Pharmaceutical Company、ProMetic Life-Sciences Inc.、BioLine Rx Ltd、Genzyme Corporation、）
・腎線維症治療の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Kidney (Renal) Fibrosis market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Kidney (Renal) Fibrosis volume and value at global level, regional level and company level. From a global perspective, this report represents overall Kidney (Renal) Fibrosis market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Kidney (Renal) Fibrosis in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Kidney (Renal) Fibrosis manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Merck
Pfizer
Roche
InterMune
Galectin Therapeutics
La Jolla Pharmaceutical Company
ProMetic Life-Sciences Inc.
BioLine Rx Ltd
Genzyme Corporation

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Angiotensin Converting enzyme (ACE) Inhibitors
Pirfenidone
Renin Inhibitors
Angiotensin II Receptor Blockers (ARBs)
Vasopeptidase Inhibitors

Segment by Application
Research Center
Hospital
Clinic

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Kidney (Renal) Fibrosis
1.1 Definition of Kidney (Renal) Fibrosis
1.2 Kidney (Renal) Fibrosis Segment by Type
1.2.1 Global Kidney (Renal) Fibrosis Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Angiotensin Converting enzyme (ACE) Inhibitors
1.2.3 Pirfenidone
1.2.4 Renin Inhibitors
1.2.5 Angiotensin II Receptor Blockers (ARBs)
1.2.6 Vasopeptidase Inhibitors
1.3 Kidney (Renal) Fibrosis Segment by Applications
1.3.1 Global Kidney (Renal) Fibrosis Consumption Comparison by Applications (2014-2025)
1.3.2 Research Center
1.3.3 Hospital
1.3.4 Clinic
1.4 Global Kidney (Renal) Fibrosis Overall Market
1.4.1 Global Kidney (Renal) Fibrosis Revenue (2014-2025)
1.4.2 Global Kidney (Renal) Fibrosis Production (2014-2025)
1.4.3 North America Kidney (Renal) Fibrosis Status and Prospect (2014-2025)
1.4.4 Europe Kidney (Renal) Fibrosis Status and Prospect (2014-2025)
1.4.5 China Kidney (Renal) Fibrosis Status and Prospect (2014-2025)
1.4.6 Japan Kidney (Renal) Fibrosis Status and Prospect (2014-2025)
1.4.7 Southeast Asia Kidney (Renal) Fibrosis Status and Prospect (2014-2025)
1.4.8 India Kidney (Renal) Fibrosis Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Kidney (Renal) Fibrosis
2.3 Manufacturing Process Analysis of Kidney (Renal) Fibrosis
2.4 Industry Chain Structure of Kidney (Renal) Fibrosis

3 Development and Manufacturing Plants Analysis of Kidney (Renal) Fibrosis
3.1 Capacity and Commercial Production Date
3.2 Global Kidney (Renal) Fibrosis Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Kidney (Renal) Fibrosis
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Kidney (Renal) Fibrosis Production and Capacity Analysis
4.2 Kidney (Renal) Fibrosis Revenue Analysis
4.3 Kidney (Renal) Fibrosis Price Analysis
4.4 Market Concentration Degree

5 Kidney (Renal) Fibrosis Regional Market Analysis
5.1 Kidney (Renal) Fibrosis Production by Regions
5.1.1 Global Kidney (Renal) Fibrosis Production by Regions
5.1.2 Global Kidney (Renal) Fibrosis Revenue by Regions
5.2 Kidney (Renal) Fibrosis Consumption by Regions
5.3 North America Kidney (Renal) Fibrosis Market Analysis
5.3.1 North America Kidney (Renal) Fibrosis Production
5.3.2 North America Kidney (Renal) Fibrosis Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Kidney (Renal) Fibrosis Import and Export
5.4 Europe Kidney (Renal) Fibrosis Market Analysis
5.4.1 Europe Kidney (Renal) Fibrosis Production
5.4.2 Europe Kidney (Renal) Fibrosis Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Kidney (Renal) Fibrosis Import and Export
5.5 China Kidney (Renal) Fibrosis Market Analysis
5.5.1 China Kidney (Renal) Fibrosis Production
5.5.2 China Kidney (Renal) Fibrosis Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Kidney (Renal) Fibrosis Import and Export
5.6 Japan Kidney (Renal) Fibrosis Market Analysis
5.6.1 Japan Kidney (Renal) Fibrosis Production
5.6.2 Japan Kidney (Renal) Fibrosis Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Kidney (Renal) Fibrosis Import and Export
5.7 Southeast Asia Kidney (Renal) Fibrosis Market Analysis
5.7.1 Southeast Asia Kidney (Renal) Fibrosis Production
5.7.2 Southeast Asia Kidney (Renal) Fibrosis Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Kidney (Renal) Fibrosis Import and Export
5.8 India Kidney (Renal) Fibrosis Market Analysis
5.8.1 India Kidney (Renal) Fibrosis Production
5.8.2 India Kidney (Renal) Fibrosis Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Kidney (Renal) Fibrosis Import and Export

6 Kidney (Renal) Fibrosis Segment Market Analysis (by Type)
6.1 Global Kidney (Renal) Fibrosis Production by Type
6.2 Global Kidney (Renal) Fibrosis Revenue by Type
6.3 Kidney (Renal) Fibrosis Price by Type

7 Kidney (Renal) Fibrosis Segment Market Analysis (by Application)
7.1 Global Kidney (Renal) Fibrosis Consumption by Application
7.2 Global Kidney (Renal) Fibrosis Consumption Market Share by Application (2014-2019)

8 Kidney (Renal) Fibrosis Major Manufacturers Analysis
8.1 Merck
8.1.1 Merck Kidney (Renal) Fibrosis Production Sites and Area Served
8.1.2 Merck Product Introduction, Application and Specification
8.1.3 Merck Kidney (Renal) Fibrosis Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Pfizer
8.2.1 Pfizer Kidney (Renal) Fibrosis Production Sites and Area Served
8.2.2 Pfizer Product Introduction, Application and Specification
8.2.3 Pfizer Kidney (Renal) Fibrosis Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Roche
8.3.1 Roche Kidney (Renal) Fibrosis Production Sites and Area Served
8.3.2 Roche Product Introduction, Application and Specification
8.3.3 Roche Kidney (Renal) Fibrosis Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 InterMune
8.4.1 InterMune Kidney (Renal) Fibrosis Production Sites and Area Served
8.4.2 InterMune Product Introduction, Application and Specification
8.4.3 InterMune Kidney (Renal) Fibrosis Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Galectin Therapeutics
8.5.1 Galectin Therapeutics Kidney (Renal) Fibrosis Production Sites and Area Served
8.5.2 Galectin Therapeutics Product Introduction, Application and Specification
8.5.3 Galectin Therapeutics Kidney (Renal) Fibrosis Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 La Jolla Pharmaceutical Company
8.6.1 La Jolla Pharmaceutical Company Kidney (Renal) Fibrosis Production Sites and Area Served
8.6.2 La Jolla Pharmaceutical Company Product Introduction, Application and Specification
8.6.3 La Jolla Pharmaceutical Company Kidney (Renal) Fibrosis Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 ProMetic Life-Sciences Inc.
8.7.1 ProMetic Life-Sciences Inc. Kidney (Renal) Fibrosis Production Sites and Area Served
8.7.2 ProMetic Life-Sciences Inc. Product Introduction, Application and Specification
8.7.3 ProMetic Life-Sciences Inc. Kidney (Renal) Fibrosis Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 BioLine Rx Ltd
8.8.1 BioLine Rx Ltd Kidney (Renal) Fibrosis Production Sites and Area Served
8.8.2 BioLine Rx Ltd Product Introduction, Application and Specification
8.8.3 BioLine Rx Ltd Kidney (Renal) Fibrosis Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Genzyme Corporation
8.9.1 Genzyme Corporation Kidney (Renal) Fibrosis Production Sites and Area Served
8.9.2 Genzyme Corporation Product Introduction, Application and Specification
8.9.3 Genzyme Corporation Kidney (Renal) Fibrosis Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served

9 Development Trend of Analysis of Kidney (Renal) Fibrosis Market
9.1 Global Kidney (Renal) Fibrosis Market Trend Analysis
9.1.1 Global Kidney (Renal) Fibrosis Market Size (Volume and Value) Forecast 2019-2025
9.2 Kidney (Renal) Fibrosis Regional Market Trend
9.2.1 North America Kidney (Renal) Fibrosis Forecast 2019-2025
9.2.2 Europe Kidney (Renal) Fibrosis Forecast 2019-2025
9.2.3 China Kidney (Renal) Fibrosis Forecast 2019-2025
9.2.4 Japan Kidney (Renal) Fibrosis Forecast 2019-2025
9.2.5 Southeast Asia Kidney (Renal) Fibrosis Forecast 2019-2025
9.2.6 India Kidney (Renal) Fibrosis Forecast 2019-2025
9.3 Kidney (Renal) Fibrosis Market Trend (Product Type)
9.4 Kidney (Renal) Fibrosis Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Kidney (Renal) Fibrosis Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Kidney (Renal) Fibrosis
Table Global Kidney (Renal) Fibrosis Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Kidney (Renal) Fibrosis Production Market Share by Types in 2018
Figure Angiotensin Converting enzyme (ACE) Inhibitors Product Picture
Figure Pirfenidone Product Picture
Figure Renin Inhibitors Product Picture
Figure Angiotensin II Receptor Blockers (ARBs) Product Picture
Figure Vasopeptidase Inhibitors Product Picture
Table Global Kidney (Renal) Fibrosis Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Kidney (Renal) Fibrosis Consumption Market Share by Applications in 2018
Figure Research Center
Figure Hospital
Figure Clinic
Figure Global Kidney (Renal) Fibrosis Revenue (Million USD) (2014-2025)
Figure Global Kidney (Renal) Fibrosis Production (K Units) (2014-2025)
Figure North America Kidney (Renal) Fibrosis Market Size (Million USD) (2014-2025)
Figure Europe Kidney (Renal) Fibrosis Market Size (Million USD) (2014-2025)
Figure China Kidney (Renal) Fibrosis Market Size (Million USD) (2014-2025)
Figure Japan Kidney (Renal) Fibrosis Market Size (Million USD) (2014-2025)
Figure Southeast Asia Kidney (Renal) Fibrosis Market Size (Million USD) (2014-2025)
Figure India Kidney (Renal) Fibrosis Market Size (Million USD) (2014-2025)
Table Kidney (Renal) Fibrosis Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Kidney (Renal) Fibrosis in 2018
Figure Manufacturing Process Analysis of Kidney (Renal) Fibrosis
Figure Industry Chain Structure of Kidney (Renal) Fibrosis
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Kidney (Renal) Fibrosis Manufacturing Plants Distribution
Table Kidney (Renal) Fibrosis Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Kidney (Renal) Fibrosis Capacity (K Units) of Major Manufacturers (2014-2019)
Table Kidney (Renal) Fibrosis Production (K Units) of Major Manufacturers (2014-2019)
Table Kidney (Renal) Fibrosis Production Market Share of Major Manufacturers (2014-2019)
Figure Kidney (Renal) Fibrosis Production Share by Manufacturers in 2018
Table Kidney (Renal) Fibrosis Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Kidney (Renal) Fibrosis Revenue Market Share of Major Manufacturers (2014-2019)
Figure Kidney (Renal) Fibrosis Revenue Share by Manufacturers in 2018
Table Kidney (Renal) Fibrosis Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Kidney (Renal) Fibrosis Production by Regions 2014-2019 (K Units)
Table Global Kidney (Renal) Fibrosis Production Market Share by Regions 2014-2019
Figure Global Kidney (Renal) Fibrosis Production Market Share by Regions in 2018
Table Global Kidney (Renal) Fibrosis Revenue by Regions 2014-2019 (Million USD)
Table Global Kidney (Renal) Fibrosis Revenue Market Share by Regions 2014-2019
Figure Global Kidney (Renal) Fibrosis Revenue Market Share by Regions in 2018
Table Global Kidney (Renal) Fibrosis Consumption by Regions 2014-2019 (K Units)
Table Global Kidney (Renal) Fibrosis Consumption Market Share by Regions 2014-2019
Figure North America Kidney (Renal) Fibrosis Production Growth Rate 2014-2019 (K Units)
Figure North America Kidney (Renal) Fibrosis Revenue Growth Rate 2014-2019 (Million USD)
Table North America Kidney (Renal) Fibrosis Production, Consumption Import and Export (K Units)
Figure Europe Kidney (Renal) Fibrosis Production Growth Rate 2014-2019 (K Units)
Figure Europe Kidney (Renal) Fibrosis Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Kidney (Renal) Fibrosis Production, Consumption Import and Export (K Units)
Figure China Kidney (Renal) Fibrosis Production Growth Rate 2014-2019 (K Units)
Figure China Kidney (Renal) Fibrosis Revenue Growth Rate 2014-2019 (Million USD)
Table China Kidney (Renal) Fibrosis Production, Consumption Import and Export (K Units)
Figure Japan Kidney (Renal) Fibrosis Production Growth Rate 2014-2019 (K Units)
Figure Japan Kidney (Renal) Fibrosis Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Kidney (Renal) Fibrosis Production, Consumption Import and Export (K Units)
Figure Southeast Asia Kidney (Renal) Fibrosis Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Kidney (Renal) Fibrosis Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Kidney (Renal) Fibrosis Production, Consumption Import and Export (K Units)
Figure India Kidney (Renal) Fibrosis Production Growth Rate 2014-2019 (K Units)
Figure India Kidney (Renal) Fibrosis Revenue Growth Rate 2014-2019 (Million USD)
Table India Kidney (Renal) Fibrosis Production, Consumption Import and Export (K Units)
Figure Global Consumption Kidney (Renal) Fibrosis Market Share by Application (2014-2019)
Figure Global Value (Consumption) Kidney (Renal) Fibrosis Market Share by Application (2014-2019)
Table Merck Kidney (Renal) Fibrosis Production Sites and Area Served
Table Merck Kidney (Renal) Fibrosis Product Introduction, Application and Specification
Table Merck Kidney (Renal) Fibrosis Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck Kidney (Renal) Fibrosis Production Growth Rate (2014-2019)
Table Merck Kidney (Renal) Fibrosis Production Market Share (2014-2019)
Figure Merck Kidney (Renal) Fibrosis Revenue Market Share (2014-2019)
Table Merck Kidney (Renal) Fibrosis Main Business and Markets Served
Table Pfizer Kidney (Renal) Fibrosis Production Sites and Area Served
Table Pfizer Kidney (Renal) Fibrosis Product Introduction, Application and Specification
Table Pfizer Kidney (Renal) Fibrosis Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Kidney (Renal) Fibrosis Production Growth Rate (2014-2019)
Table Pfizer Kidney (Renal) Fibrosis Production Market Share (2014-2019)
Figure Pfizer Kidney (Renal) Fibrosis Revenue Market Share (2014-2019)
Table Pfizer Kidney (Renal) Fibrosis Main Business and Markets Served
Table Roche Kidney (Renal) Fibrosis Production Sites and Area Served
Table Roche Kidney (Renal) Fibrosis Product Introduction, Application and Specification
Table Roche Kidney (Renal) Fibrosis Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Roche Kidney (Renal) Fibrosis Production Growth Rate (2014-2019)
Table Roche Kidney (Renal) Fibrosis Production Market Share (2014-2019)
Figure Roche Kidney (Renal) Fibrosis Revenue Market Share (2014-2019)
Table Roche Kidney (Renal) Fibrosis Main Business and Markets Served
Table InterMune Kidney (Renal) Fibrosis Production Sites and Area Served
Table InterMune Kidney (Renal) Fibrosis Product Introduction, Application and Specification
Table InterMune Kidney (Renal) Fibrosis Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table InterMune Kidney (Renal) Fibrosis Production Growth Rate (2014-2019)
Table InterMune Kidney (Renal) Fibrosis Production Market Share (2014-2019)
Figure InterMune Kidney (Renal) Fibrosis Revenue Market Share (2014-2019)
Table InterMune Kidney (Renal) Fibrosis Main Business and Markets Served
Table Galectin Therapeutics Kidney (Renal) Fibrosis Production Sites and Area Served
Table Galectin Therapeutics Kidney (Renal) Fibrosis Product Introduction, Application and Specification
Table Galectin Therapeutics Kidney (Renal) Fibrosis Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Galectin Therapeutics Kidney (Renal) Fibrosis Production Growth Rate (2014-2019)
Table Galectin Therapeutics Kidney (Renal) Fibrosis Production Market Share (2014-2019)
Figure Galectin Therapeutics Kidney (Renal) Fibrosis Revenue Market Share (2014-2019)
Table Galectin Therapeutics Kidney (Renal) Fibrosis Main Business and Markets Served
Table La Jolla Pharmaceutical Company Kidney (Renal) Fibrosis Production Sites and Area Served
Table La Jolla Pharmaceutical Company Kidney (Renal) Fibrosis Product Introduction, Application and Specification
Table La Jolla Pharmaceutical Company Kidney (Renal) Fibrosis Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table La Jolla Pharmaceutical Company Kidney (Renal) Fibrosis Production Growth Rate (2014-2019)
Table La Jolla Pharmaceutical Company Kidney (Renal) Fibrosis Production Market Share (2014-2019)
Figure La Jolla Pharmaceutical Company Kidney (Renal) Fibrosis Revenue Market Share (2014-2019)
Table La Jolla Pharmaceutical Company Kidney (Renal) Fibrosis Main Business and Markets Served
Table ProMetic Life-Sciences Inc. Kidney (Renal) Fibrosis Production Sites and Area Served
Table ProMetic Life-Sciences Inc. Kidney (Renal) Fibrosis Product Introduction, Application and Specification
Table ProMetic Life-Sciences Inc. Kidney (Renal) Fibrosis Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table ProMetic Life-Sciences Inc. Kidney (Renal) Fibrosis Production Growth Rate (2014-2019)
Table ProMetic Life-Sciences Inc. Kidney (Renal) Fibrosis Production Market Share (2014-2019)
Figure ProMetic Life-Sciences Inc. Kidney (Renal) Fibrosis Revenue Market Share (2014-2019)
Table ProMetic Life-Sciences Inc. Kidney (Renal) Fibrosis Main Business and Markets Served
Table BioLine Rx Ltd Kidney (Renal) Fibrosis Production Sites and Area Served
Table BioLine Rx Ltd Kidney (Renal) Fibrosis Product Introduction, Application and Specification
Table BioLine Rx Ltd Kidney (Renal) Fibrosis Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table BioLine Rx Ltd Kidney (Renal) Fibrosis Production Growth Rate (2014-2019)
Table BioLine Rx Ltd Kidney (Renal) Fibrosis Production Market Share (2014-2019)
Figure BioLine Rx Ltd Kidney (Renal) Fibrosis Revenue Market Share (2014-2019)
Table BioLine Rx Ltd Kidney (Renal) Fibrosis Main Business and Markets Served
Table Genzyme Corporation Kidney (Renal) Fibrosis Production Sites and Area Served
Table Genzyme Corporation Kidney (Renal) Fibrosis Product Introduction, Application and Specification
Table Genzyme Corporation Kidney (Renal) Fibrosis Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Genzyme Corporation Kidney (Renal) Fibrosis Production Growth Rate (2014-2019)
Table Genzyme Corporation Kidney (Renal) Fibrosis Production Market Share (2014-2019)
Figure Genzyme Corporation Kidney (Renal) Fibrosis Revenue Market Share (2014-2019)
Table Genzyme Corporation Kidney (Renal) Fibrosis Main Business and Markets Served
Figure Global Kidney (Renal) Fibrosis Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Kidney (Renal) Fibrosis Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Kidney (Renal) Fibrosis Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Kidney (Renal) Fibrosis Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Kidney (Renal) Fibrosis Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Kidney (Renal) Fibrosis Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Kidney (Renal) Fibrosis Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Kidney (Renal) Fibrosis Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Kidney (Renal) Fibrosis Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Kidney (Renal) Fibrosis Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Kidney (Renal) Fibrosis Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Kidney (Renal) Fibrosis Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia Kidney (Renal) Fibrosis Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Kidney (Renal) Fibrosis Production Growth Rate Forecast 2019-2025 (K Units)
Figure India Kidney (Renal) Fibrosis Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Kidney (Renal) Fibrosis by Type (2019-2025)
Table Global Consumption (K Units) of Kidney (Renal) Fibrosis by Application (2019-2025)
Table Kidney (Renal) Fibrosis Distributors List
Table Kidney (Renal) Fibrosis Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Merck、Pfizer、Roche、InterMune、Galectin Therapeutics、La Jolla Pharmaceutical Company、ProMetic Life-Sciences Inc.、BioLine Rx Ltd、Genzyme Corporation、

★調査レポート[世界の腎線維症治療市場 2019年] (コード：DATA909X10187)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の腎線維症治療市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の特発性肺線維症薬市場 2019年
    DATA909X09542 / QYResearch / 2019年11月20日 / ※本調査レポートは、特発性肺線維症薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、グルココルチコイド、免疫抑制剤、その他に、用途別には、病院、診療所、その他にセグメント区分し、特発性肺線維症薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・特発性肺線維症薬の世界市場概要 ・特発性肺線維症薬の製造コスト構成分析 ・特発性肺線維症薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・特発性肺線維症薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・特発性肺線維症薬のセグメント分析（種類別） （グルココルチコイド、免疫抑制剤、その他）...The global Idiopathic Pulmonary Fibrosis Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Idiopathic Pulmonary Fibrosis Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Idiopathic Pulmonary Fibrosis Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Idiopathic Pulmonary Fibrosis Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界の腎除神経カテーテル市場 2019年
    DATA909X14277 / QYResearch / 2019年11月20日 / ※本調査レポートは、腎除神経カテーテルの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、経皮カテーテル、その他に、用途別には、病院、医療センター、その他にセグメント区分し、腎除神経カテーテルの世界市場を分析しました。 ・エグゼクティブ・サマリー ・腎除神経カテーテルの世界市場概要 ・腎除神経カテーテルの製造コスト構成分析 ・腎除神経カテーテルの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・腎除神経カテーテルの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・腎除神経カテーテルのセグメント分析（種類別） （経皮カテーテル、その他）...The global Renal Denervation Catheter market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Renal Denervation Catheter volume and value at global level, regional level and company level. From a global perspective, this report represents overall Renal Denervation Catheter market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Renal Denervation Catheter in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の末期腎不全（ESRD）薬市場 2019年
    DATA909X07327 / QYResearch / 2019年11月15日 / ※本調査レポートは、末期腎不全（ESRD）薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、コハク酸カルシウム、Mk-3866、パクリチニブ、サンギネート、テシドールマブ、その他に、用途別には、病院、診療所、ICU、その他にセグメント区分し、末期腎不全（ESRD）薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・末期腎不全（ESRD）薬の世界市場概要 ・末期腎不全（ESRD）薬の製造コスト構成分析 ・末期腎不全（ESRD）薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・末期腎不全（ESRD）薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・末期腎不全（ESRD）薬のセグメント分析（種類別） （コハク酸カルシウム、Mk-3866、パクリチニブ、サンギネート、テシドールマブ、その他）...The global End-Stage Renal Disease (ESRD) Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on End-Stage Renal Disease (ESRD) Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall End-Stage Renal Disease (ESRD) Drugs market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of End-Stage Renal Disease (ESRD) Drugs in North America, Europe, China, Japan, Southeast Asia and...
  • 世界の腎機能検査製品市場 2019年
    DATA909X14278 / QYResearch / 2019年11月20日 / ※本調査レポートは、腎機能検査製品の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ディップスティック、試薬、ディスポーザブルに、用途別には、病院、診断研究所、研究所および研究所にセグメント区分し、腎機能検査製品の世界市場を分析しました。 ・エグゼクティブ・サマリー ・腎機能検査製品の世界市場概要 ・腎機能検査製品の製造コスト構成分析 ・腎機能検査製品の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・腎機能検査製品の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・腎機能検査製品のセグメント分析（種類別） （ディップスティック、試薬、ディスポーザブル）...The global Renal Function Test Product market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Renal Function Test Product volume and value at global level, regional level and company level. From a global perspective, this report represents overall Renal Function Test Product market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Renal Function Test Product in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界の腎細胞がん薬市場 2019年
    DATA909X14276 / QYResearch / 2019年11月20日 / ※本調査レポートは、腎細胞がん薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、Sutent（スニチニブ）、Nexavar（ソラフェニブ）、Votrient（パゾパニブ）、Avastin（ベバシズマブ）、Afinitor（エベロリムス）、Inlyta（アキシチニブ）、Torisel（テムシロリムス）、Proleukin（アルデスロイキン）に、用途別には、粘液性尿細管および紡錘細胞癌（MTSCC）、多房性嚢胞性明細胞腎細胞癌、尿細管嚢胞腎細胞癌、甲状腺様濾胞腎細胞癌、その他にセグメント区分し、腎細胞がん薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・腎細胞がん薬の世界市場概要 ・腎細胞がん薬の製造コスト構成分析 ・腎細胞がん薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・腎細胞がん薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・腎細胞がん薬のセグメント分析（種類別） （Sutent（スニチニブ）、Nexavar（ソラフェニブ）、Votrient（パゾパニブ）、Avastin（ベバシズマブ）、Afinitor（エベロリムス）、Inlyta（アキシチニブ）、Torisel（テムシロリムス）、Proleukin（アルデスロイキン））...The global Renal Cell Cacinoma Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Renal Cell Cacinoma Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Renal Cell Cacinoma Drugs market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Renal Cell Cacinoma Drugs in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...

    • ◆H&Iグローバルリサーチのお客様（例）◆